VSIR and congenital rubella syndrome: Our human in vitro and ex vivo, murine in vivo CRS, and NHP safety data demonstrate that SNS-101 significantly mitigates, if not eliminates, cytokine release due its lack of VISTA binding at physiologic pH (Supplementary Fig. 13).